Crosstalk between Glycogen-Selective Autophagy, Autophagy and Apoptosis as a Road towards Modifier Gene Discovery and New Therapeutic Strategies for Glycogen Storage Diseases
- PMID: 36143432
- PMCID: PMC9504455
- DOI: 10.3390/life12091396
Crosstalk between Glycogen-Selective Autophagy, Autophagy and Apoptosis as a Road towards Modifier Gene Discovery and New Therapeutic Strategies for Glycogen Storage Diseases
Abstract
Glycogen storage diseases (GSDs) are rare metabolic monogenic disorders characterized by an excessive accumulation of glycogen in the cell. However, monogenic disorders are not simple regarding genotype-phenotype correlation. Genes outside the major disease-causing locus could have modulatory effect on GSDs, and thus explain the genotype-phenotype inconsistencies observed in these patients. Nowadays, when the sequencing of all clinically relevant genes, whole human exomes, and even whole human genomes is fast, easily available and affordable, we have a scientific obligation to holistically analyze data and draw smarter connections between genotype and phenotype. Recently, the importance of glycogen-selective autophagy for the pathophysiology of disorders of glycogen metabolism have been described. Therefore, in this manuscript, we review the potential role of genes involved in glycogen-selective autophagy as modifiers of GSDs. Given the small number of genes associated with glycogen-selective autophagy, we also include genes, transcription factors, and non-coding RNAs involved in autophagy. A cross-link with apoptosis is addressed. All these genes could be analyzed in GSD patients with unusual discrepancies between genotype and phenotype in order to discover genetic variants potentially modifying their phenotype. The discovery of modifier genes related to glycogen-selective autophagy and autophagy will start a new chapter in understanding of GSDs and enable the usage of autophagy-inducing drugs for the treatment of this group of rare-disease patients.
Keywords: apoptosis; autophagy; autophagy-inducing drugs; glycogen storage diseases; glycogen-selective autophagy; modifier genes.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Mitochondrial Dysfunction in Glycogen Storage Disorders (GSDs).Biomolecules. 2024 Sep 1;14(9):1096. doi: 10.3390/biom14091096. Biomolecules. 2024. PMID: 39334863 Free PMC article. Review.
-
Broadening the Phenotype and Genotype Spectrum of Glycogen Storage Disease by Unraveling Novel Variants in an Iranian Patient Cohort.Biochem Genet. 2025 Apr;63(2):1752-1779. doi: 10.1007/s10528-024-10787-5. Epub 2024 Apr 15. Biochem Genet. 2025. PMID: 38619706
-
Neurological glycogen storage diseases and emerging therapeutics.Neurotherapeutics. 2024 Sep;21(5):e00446. doi: 10.1016/j.neurot.2024.e00446. Epub 2024 Sep 14. Neurotherapeutics. 2024. PMID: 39277505 Free PMC article. Review.
-
Evaluation of Glycogen Storage Patients: Report of Twelve Novel Variants and New Clinical Findings in a Turkish Population.Genes (Basel). 2021 Dec 15;12(12):1987. doi: 10.3390/genes12121987. Genes (Basel). 2021. PMID: 34946936 Free PMC article.
-
Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).Genet Med. 2019 Apr;21(4):772-789. doi: 10.1038/s41436-018-0364-2. Epub 2019 Jan 19. Genet Med. 2019. PMID: 30659246
Cited by
-
Clinical and Genetic Profile of 35 Patients with Glycogen Storage Disease Type 1b: A Comparative Analysis Before and During SGLT2 Inhibitor Therapy.Mol Diagn Ther. 2025 Jun 19. doi: 10.1007/s40291-025-00795-5. Online ahead of print. Mol Diagn Ther. 2025. PMID: 40536628
-
An update on autophagy disorders.J Inherit Metab Dis. 2025 Jan;48(1):e12798. doi: 10.1002/jimd.12798. Epub 2024 Oct 17. J Inherit Metab Dis. 2025. PMID: 39420677 Free PMC article. Review.
-
Pyrrolidine Dithiocarbamate Ameliorates Sepsis-Associated Encephalopathy by Inhibiting Autophagy and Inflammation in the Brain.Neurochem Res. 2025 Feb 27;50(2):106. doi: 10.1007/s11064-025-04355-5. Neurochem Res. 2025. PMID: 40011296 Free PMC article.
-
Phenylbutyric Acid Modulates Apoptosis and ER Stress-Related Gene Expression in Glycogen Storage Disease Type Ib In Vitro Model.Mol Genet Genomic Med. 2025 Jan;13(1):e70054. doi: 10.1002/mgg3.70054. Mol Genet Genomic Med. 2025. PMID: 39803753 Free PMC article.
References
-
- Kishnani P.S., Beckemeyer A.A. New therapeutic approaches for Pompe disease: Enzyme replacement therapy and beyond. Pediatr. Endocrinol. Rev. 2014;12((Suppl. S1)):114–124. - PubMed
-
- Kakhlon O., Vaknin H., Mishra K., D’Souza J., Marisat M., Sprecher U., Wald-Altman S., Dukhovny A., Raviv Y., Da’Adoosh B., et al. Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism. EMBO Mol. Med. 2021;13:e14554. doi: 10.15252/emmm.202114554. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources